Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan.

Although the use of placebo in clinical trials of schizophrenia patients is controversial because of medical and ethical concerns, placebo-controlled clinical trials are commonly used in the licensing of new drugs.The objective of this study was to assess the attitudes toward placebo-controlled clin...

Full description

Bibliographic Details
Main Authors: Norio Sugawara, Masamichi Ishioka, Shoko Tsuchimine, Koji Tsuruga, Yasushi Sato, Hanako Furukori, Shuhei Kudo, Tetsu Tomita, Taku Nakagami, Norio Yasui-Furukori
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4658191?pdf=render